Weiter zum Inhalt
Toggle navigation
English
English
Favoritenliste (
0
)
(Voll)
Kontakt
Mein Konto
Abmeldung
Mein Konto
Suche
Erweiterte Suche bearbeiten
Filter bei nächster Suche beibehalten
publishDate:"[2019 TO 2021]"
journalStr:"ClinicalTrials.gov"
topic_facet:"Phase: Phase 2"
topic_facet:"Recruitment Status: Completed"
Erweiterte Suche
Suchverlauf
Struktursuche
Narrative Service
Drug Overviews
Info Guide
/vufind/Search/Results?filter%5B%5D=publishDate%3A%22%5B2019+TO+2021%5D%22&filter%5B%5D=journalStr%3A%22ClinicalTrials.gov%22&filter%5B%5D=topic_facet%3A%22Phase%3A+Phase+2%22&filter%5B%5D=topic_facet%3A%22Recruitment+Status%3A+Completed%22&join=AND&bool0%5B%5D=AND&lookfor0%5B%5D=%22novel+coronavirus%22+OR+Covid+OR+%22Sars-CoV%22+OR+%22CoV-2%22+OR+ncov&type0%5B%5D=AllFields&op0%5B%5D=OR
/vufind/Search/Results?filter%5B%5D=publishDate%3A%22%5B2019+TO+2021%5D%22&filter%5B%5D=journalStr%3A%22ClinicalTrials.gov%22&filter%5B%5D=topic_facet%3A%22Phase%3A+Phase+2%22&filter%5B%5D=topic_facet%3A%22Recruitment+Status%3A+Completed%22&join=AND&bool0%5B%5D=AND&lookfor0%5B%5D=%22novel+coronavirus%22+OR+Covid+OR+%22Sars-CoV%22+OR+%22CoV-2%22+OR+ncov&type0%5B%5D=AllFields&op0%5B%5D=OR
Search /vufind/Search2/Results?filter%5B%5D=publishDate%3A%22%5B2019+TO+2021%5D%22&filter%5B%5D=journalStr%3A%22ClinicalTrials.gov%22&filter%5B%5D=topic_facet%3A%22Phase%3A+Phase+2%22&filter%5B%5D=topic_facet%3A%22Recruitment+Status%3A+Completed%22&join=AND&bool0%5B%5D=AND&lookfor0%5B%5D=%22novel+coronavirus%22+OR+Covid+OR+%22Sars-CoV%22+OR+%22CoV-2%22+OR+ncov&type0%5B%5D=AllFields&op0%5B%5D=OR
PubPharm (119)
1
Infusion of Prostacyclin (Iloprost) vs Placebo for 72-hours in COVID-19 Patients With Respiratory Failure : Efficacy and Safety of 72-hour Infusion of Prostacyclin (1 Nanogram(ng)/ Kilo(kg)/Minute(Min)) in Patients With COVID-19 Induced Pulmonary Endotheliopathy
enthalten in:
ClinicalTrials.gov
| 2021
Wird geladen...
2
An Investigation on the Effects of Icosapent Ethyl (VascepaTM) on Inflammatory Biomarkers in Individuals With COVID-19 : An Investigation on the Effects of Icosapent Ethyl (VascepaTM) on Inflammatory Biomarkers in Individuals With COVID-19 (VASCEPA-COVID-19)
enthalten in:
ClinicalTrials.gov
| 2021
Wird geladen...
3
A Study to Assess the Efficacy and Safety of Gimsilumab in Subjects With Lung Injury or Acute Respiratory Distress Syndrome Secondary to COVID-19 (BREATHE) : A Multi-Center, Adaptive, Randomized, Double-blind, Placebo-controlled Study to Assess the Efficacy and Safety of Gimsilumab in Subjects With Lung Injury or Acute Respiratory Distress Syndrome Secondary to COVID-19 (BREATHE)
enthalten in:
ClinicalTrials.gov
| 2021
Wird geladen...
4
Atovaquone for Treatment of COVID-19 : Atovaquone for Treatment of COVID-19
enthalten in:
ClinicalTrials.gov
| 2021
Wird geladen...
5
A Study of COVID 19 Convalescent Plasma in High Risk Patients With COVID 19 Infection : A Phase 2 Study of COVID 19 Convalescent Plasma in High Risk Patients With COVID 19 Infection
enthalten in:
ClinicalTrials.gov
| 2021
Wird geladen...
6
Randomized Phase IIA Clinical Trial to Evaluate the Efficacy of Ivermectin to Obtain Negative PCR Results in Patients With Early Phase COVID-19 : Randomized Phase IIA Clinical Trial to Evaluate the Efficacy of Ivermectin to Obtain Negative PCR Results in Patients With Early Phase COVID-19
enthalten in:
ClinicalTrials.gov
| 2021
Wird geladen...
7
Coronavirus Disease 2019 (COVID-19) Antibody Plasma Research Study in Hospitalized Patients : IGHID 12021 - A Randomized, Phase II Study Comparing the Efficacy and Safety of Standard Versus High-Titer Anti-Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Neutralizing Antibody Plasma in Hospitalized Patients With COVID-19
enthalten in:
ClinicalTrials.gov
| 2021
Wird geladen...
8
Therapeutic Plasma Exchange Alone or in Combination With Ruxolitinib in COVID-19 Associated CRS : Interventional Study to Evaluate the Efficacy of Therapeutic Plasma Exchange (TPE) Alone or in Combination With Ruxolitinib in COVID-19 Positive Patients With PENN Grade 2, 3, 4 Cytokine Released Syndrome (CRS)
enthalten in:
ClinicalTrials.gov
| 2021
Wird geladen...
9
Efficacy and Safety of hzVSF-v13 in Patients With COVID-19 Pneumonia : Efficacy and Safety of Intravenously Administered hzVSF-v13 in Patients With COVID-19 Pneumonia: a Phase II, Proof of Concept, Multicentre, Randomized, Parallel-group, Double-blind, Placebo-controlled Study
enthalten in:
ClinicalTrials.gov
| 2021
Wird geladen...
10
Single-Blind Study of a Single Dose of Peginterferon Lambda-1a Compared With Placebo in Outpatients With Mild COVID-19 : A Phase 2 Randomized, Single-Blind Study of a Single Dose of Peginterferon Lambda-1a (Lambda) Compared With Placebo in Outpatients With Mild COVID-19
enthalten in:
ClinicalTrials.gov
| 2021
Wird geladen...
1
2
3
4
5
6
7
8
9
10
11
Nächster »
[12]
Filter & Sortierung
Treffer pro Seite
10
20
50
Sortieren
Relevanz
Neueste zuerst
Älteste zuerst
Verfasser
Zeitschriftentitel
Bibliothek
Standort (Printmedien)
Verwandte Substanzen
Verwandte Substanzen werden ermittelt...
Verwandte Erkrankungen/Symptome
Verwandte Erkrankungen/Symptome werden ermittelt...
Verwandte Gene
Verwandte Gene werden ermittelt...
Systematic Reviews
Clinical Studies
Patente
Covid-19/SARS-CoV-2
Exclude Systematic Reviews
Exclude Clinical Studies
Exclude Patents
Ihre gewählten Filter
Filter bei nächster Suche beibehalten
Filter aufheben
Alle gewählten Filter entfernen
Filter aufheben
Erscheinungsjahr: 2019-2021
Filter aufheben
Zeitschrift: ClinicalTrials.gov
Filter aufheben
Thema: Phase: Phase 2
Filter aufheben
Thema: Recruitment Status: Completed
Medienart
119
Aufsätze
119
E-Artikel
119
E-Ressourcen
Zeitschriftentitel
ClinicalTrials.gov
Thema
119
610
Phase: Phase 2
Recruitment Status: Completed
119
Study Type: Interventional
38
Medical Condition: COVID-19
30
COVID-19
23
Coronavirus Infections
17
Pneumonia
14
Infection
12
Medical Condition: Covid19
11
Severe Acute Respiratory Syndrome
8
Syndrome
7
Acute Lung Injury
7
Communicable Diseases
7
Respiratory Distress Syndrome, Newborn
6
Respiratory Insufficiency
5
Respiratory Distress Syndrome, Adult
3
Medical Condition: COVID
3
Respiratory Distress Syndrome
3
Virus Diseases
Alle anzeigen ...
weniger ...
Erscheinungszeitraum
2019-2021
100
2021
19
2020
Erscheinungsjahr(e)
Von:
Bis:
Sprache
119
Englisch
Haven't found what you're looking for?
Wird geladen...